Evidence map›Paper›PMID 38108203›Full record

ArticleInternational journal of cancer2024

Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.

Christiana Kartsonaki, Pang Yao, Julia Butt, Rima Jeske, Catherine de Martel, Martyn Plummer, Dianjianyi Sun, Sarah Clark, Robin G Walters, Yiping Chen and 9 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trends inThe Lancet regional health. Western Pacific · 2026
    Article
  2. Article
  3. Review
  4. Hepatitis B Virus,Journal of clinical medicine · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 5 countries.

Christiana KartsonakiClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0002-3981-3418
Pang YaoClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Julia ButtInfections and Cancer Epidemiology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0001-7738-8611
Rima JeskeInfections and Cancer Epidemiology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Catherine de MartelEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-3642-277X
Martyn PlummerDepartment of Statistics, University of Warwick, Coventry, UK.ORCID 0000-0001-5130-6497
Dianjianyi SunDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
Sarah ClarkClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Robin G WaltersClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Yiping ChenClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Jun LvDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.ORCID 0000-0001-7916-3870
Canqing YuDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.ORCID 0000-0002-0019-0014
Michael HillClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Richard PetoClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Liming LiDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
Tim WaterboerInfections and Cancer Epidemiology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zhengming ChenClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Iona Y MillwoodClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0002-0807-0682
Ling YangClinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0001-5750-6588
Population Council · INPeking University · CNGerman Cancer Research Center · DEUniversity of Oxford · GBCentre international de recherche sur le cancer · FRUniversity of Warwick · GB

Funding

British Heart Foundation CH/1996001/9454Cancer Research UK 24504Cancer Research UK C16077/A29186Cancer Research UK C500/A16896Medical Research Council MC_U137686851Medical Research Council MC_UU_00017/1Medical Research Council MC_UU_12026/2Wellcome Trust 088158Wellcome Trust 104085Wellcome Trust 202922Wellcome Trust 212946World Health Organization 001
6 · The paper itself

Abstract

Infection by certain pathogens is associated with cancer development. We conducted a case-cohort study of ~2500 incident cases of esophageal, gastric and duodenal cancer, and gastric and duodenal ulcer and a randomly selected subcohort of ~2000 individuals within the China Kadoorie Biobank study of >0.5 million adults. We used a bead-based multiplex serology assay to measure antibodies against 19 pathogens (total 43 antigens) in baseline plasma samples. Associations between pathogens and antigen-specific antibodies with risks of site-specific cancers and ulcers were assessed using Cox regression fitted using the Prentice pseudo-partial likelihood. Seroprevalence varied for different pathogens, from 0.7% for Hepatitis C virus (HCV) to 99.8% for Epstein-Barr virus (EBV) in the subcohort. Compared to participants seronegative for the corresponding pathogen, Helicobacter pylori seropositivity was associated with a higher risk of non-cardia (adjusted hazard ratio [HR] 2.73 [95% CI: 2.09-3.58]) and cardia (1.67 [1.18-2.38]) gastric cancer and duodenal ulcer (2.71 [1.79-4.08]). HCV was associated with a higher risk of duodenal cancer (6.23 [1.52-25.62]) and Hepatitis B virus was associated with higher risk of duodenal ulcer (1.46 [1.04-2.05]). There were some associations of antibodies again some herpesviruses and human papillomaviruses with risks of gastrointestinal cancers and ulcers but these should be interpreted with caution. This first study of multiple pathogens with risk of gastrointestinal cancers and ulcers demonstrated that several pathogens are associated with risks of gastrointestinal cancers and ulcers. This will inform future investigations into the role of infection in the etiology of these diseases.

Indexed as

Duodenal NeoplasmsDuodenal UlcerEpstein-Barr Virus InfectionsGastrointestinal NeoplasmsHelicobacter InfectionsHelicobacter pyloriHepatitis CAdultCardiaCohort StudiesHerpesvirus 4, HumanHumansSeroepidemiologic StudiesUlcerduodenal cancerduodenal ulceresophageal cancergastric cancerinfectious pathogens

Identifiers

PMID38108203
PMCPMC7615747
OpenAlexW4389900285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.